In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings

American Journal of Clinical Nutrition

Volumn 73, Issue 2 SUPPL., 2001, Pages

  Dunne, C ^a   O'Mahony, L ^a   Murphy, L ^a   Thornton, G ^a   Morrissey, D ^a   O'Halloran, S ^a   Feeney, M ^a   Flynn, S ^a   Fitzgerald, G ^a   Daly, C ^a   Kiely, B ^a   O'Sullivan, G C ^a   Shanahan, F ^a   Collins, J K ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Assessment; Bacteria; Feeding studies; Human studies; Isolation; Lactic acid; Mouse studies; Probiotics; Selection criteria

Indexed keywords

PROBIOTIC AGENT;

ANIMAL EXPERIMENT; BACTERIUM ISOLATION; CLINICAL TRIAL; CONFERENCE PAPER; DOUBLE BLIND PROCEDURE; FOOD; HUMAN; HUMAN CELL; ILEUM; IMMUNE RESPONSE; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS; LACTOBACILLUS SALIVARIUS; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; STRAIN DIFFERENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); LACTOBACILLUS; LACTOBACILLUS SALIVARIUS; LACTOBACILLUS SALIVARIUS SUBSP. SALIVARIUS; MURINAE; POSIBACTERIA;

EID: 0035147206     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/73.2.386s     Document Type: Conference Paper

References (85)

1. Gut flora in normal and diseased states
2. Lactic acid bacteria in health and disease
3. Application of lactic acid bacteria in novel foods from a nutritional perspective
4. The biotechnology of lactic acid bacteria with emphasis on applications in food safety and human health
5. Ecological control of the gastrointestinal tract. The role of probiotic bacteria
6. A review: Probiotics in man and animals
7. Probiotics
8. The prolongation of life
9. Lactobacillus GG: A human probiotic strain with thorough clinical documentation
10. Prophylactic effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer
11. The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans
12. Lactobacillus acidophilus LA-1 binds to cultured human intestinal cell-lines and inhibits cell attachment and cell invasion by enterovirulent bacteria
13. Bringing a probiotic-containing functional food to the market: Microbiological, product, regulatory and labeling issues
14. Lactic acid bacteria as promoters of human health
15. Demonstration Project FAIR CT96-1028
16. The future of functional foods: Scientific basis and future requirements
17. Potential of using lactic acid bacteria for therapy and immunomodulation in man
18. Probiotic properties of lactic-acid bacteria: Plenty of scope for fundamental R & D
19. Selection criteria for probiotic microorganisms
20. Clinical uses of probiotics for stabilizing the gut mucosal barrier: Successful strains and future challenges
21. Probiotics, prebiotics or "conbiotics."
22. Establishing a scientific basis for probiotic R & D
23. Probiotics for humans
24. Lactic acid bacteria in health and disease
25. Effect of Lactobacillus acidophilus supplements on mutagen excretion in feces and urine in humans
26. Enhancement of the circulatory antibody screening cell response in human diarrhea by a human Lactobacillus strain
27. Viable versus inactivated Lactobacillus GG in acute rotavirus diarrhea
28. Lactic acid bacteria in the treatment of acute rotavirus gastroenterol
29. Lactobacillus GG promotes recovery from acute nonbloody diarrhea in Pakistan
30. Survival of yogurt-containing organisms and Lactobacillus gasseri (ADH) and their effect on bacterial enzyme activity in the gastrointestinal tract of healthy and hypochlorhydric elderly subjects
31. Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans
32. Prevention of Clostridium difficile-induced experimental pseudomembranous colitis by Saccharomyces boulardii: A scanning electron microscopic and microbiological study
33. The coming age of probiotics
34. Probiotic bacteria: Myth or reality?
35. Regular, non-sporing gram positive rods
36. Distribution of indigenous bacteria in the digestive tract of conventional and gnotobiotic rats
37. Development of anaerobic fecal flora in healthy new-born infants
38. Taxonomy and ecology of bifidobacteria
39. Numerical taxonomy of Lactobacillus sp. associated with healthy and diseased mucosa of the human intestines
40. Probiotic bacteria
41. Determination of genetic diversity within the genus Bifidobacterium and estimation of chromosomal size
42. Selection of probiotic strains for human applications
43. Lactobacillus colonization of the gastrointestinal tract of mice after removal of the nonsecreting stomach region
44. The fate and effects of transiting, nonpathogenic micro-organisms in the human intestine
45. A medium for the cultivation of lactobacilli
46. Studies on the intestinal flora. 1. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons
47. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells
48. Survival of Lactobacillus sp. (strain GG) in the human gastrointestinal tract
49. Description and stimulation of a physiological pharmokinetic model for the metabolism and enterohepatic circulation of bile acids in man
50. Degradation of bile salts by human intestinal bacteria
51. Deconjugation of bile acids by intestinal bacteria: A review of literature and additional studies
52. Biotransformation of bile acids and cholesterol by the intestinal microflora
53. Modification of bile acids by intestinal bacteria
54. Antibacterial activity of bile acids against common biliary tract organisms
55. The effect of bile acids on intestinal microflora
56. Bile acids: A pH dependent antibacterial system in the gut?
57. Adhesion of colonization factor antigen II-positive enterotoxigenic Escherichia coli strains to human enterocyte-like differentiated HT-29 cells: A basis for host-pathogen interactions in the gut
58. Use of purified F1845 fimbrial adhesin to study localization and expression of receptors for diffusely adhering Escherichia coli during enterocytic differentiation of human colon carcinoma cell lines HT-29 and Caco-2 in culture
59. Competitive exclusion of diarrheagenic Escherichia coli (ETEC) from human enterocyte-like Caco-2 cells by heat-killed Lactobacillus
60. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion
61. Protein-mediated adhesion of Lactobacillus acidophilus BG2FO4 on human enterocyte and mucus-secreting cell lines in culture
62. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions
63. Factors involved in adherence of lactobacilli to human Caco-2 cells
64. Adhesion of different bifidobacteria strains to human enterocyte-like Caco-2 cells and comparison with in vivo study
65. Comparison of the adherence of three Lactobacillus strains to Caco-2 and Int-407 human intestinal cell lines
66. Adhesion of some probiotic and dairy Lactobacillus strains to Caco-2 cell cultures
67. Antimicrobial components from lactic acid bacteria
68. Kinetic studies of the action of Lactacin F, a bacteriocin produced by Lactobacillus johnsonii that forms poration complexes in the cytoplasmic membrane
69. Lacticin 3147, a broad-spectrum bacteriocin which selectively dissipates the membrane potential
70. Bacteriocins of lactic acid bacteria
71. Bacteriocins of gram positive bacteria
72. Enteral feeding of premature infants with Lactobacillus GG
73. Effect of administration of Lactobacillus casei strain GG on the gastrointestinal microbiota of newborns
74. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis
75. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG
76. Effect of Lactobacillus GG yogurt in prevention of antibiotic-associated diarrhea
77. Prevention of traveler's diarrhea by Lactobacillus GG
78. In vivo assessment of potential probiotic Lactobacillus salivarius strains: Evaluation of their establishment, persistence, and localization in the murine gastrointestinal tract
79. Methods of analysis of the intestinal micro-flora
80. Functionality of probiotics and intestinal lactobacilli: Light in the intestinal tract tunnel
81. Identification of mesophilic lactic acid bacteria by using polymerase chain reaction-amplified variable regions of 16S rRNA and specific DNA probes
82. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria
83. Analysis of the intestinal microflora: A renaissance
84. Probiotics and man: The host microbe interface
85. Probiotics: From myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials